JP2021514185A5 - - Google Patents
Info
- Publication number
- JP2021514185A5 JP2021514185A5 JP2020543276A JP2020543276A JP2021514185A5 JP 2021514185 A5 JP2021514185 A5 JP 2021514185A5 JP 2020543276 A JP2020543276 A JP 2020543276A JP 2020543276 A JP2020543276 A JP 2020543276A JP 2021514185 A5 JP2021514185 A5 JP 2021514185A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- notch ligand
- cell
- positive
- cell lineage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023191915A JP7866537B2 (ja) | 2018-02-14 | 2023-11-10 | Ｔ細胞系列の細胞を発生させるための方法 |
| JP2025216743A JP2026031647A (ja) | 2018-02-14 | 2025-12-02 | Ｔ細胞系列の細胞を発生させるための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862630497P | 2018-02-14 | 2018-02-14 | |
| US62/630,497 | 2018-02-14 | ||
| PCT/CA2019/050181 WO2019157597A1 (en) | 2018-02-14 | 2019-02-14 | Method for generating cells of the t cell lineage |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023191915A Division JP7866537B2 (ja) | 2018-02-14 | 2023-11-10 | Ｔ細胞系列の細胞を発生させるための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021514185A JP2021514185A (ja) | 2021-06-10 |
| JP2021514185A5 true JP2021514185A5 (cg-RX-API-DMAC7.html) | 2022-02-10 |
Family
ID=67619677
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543276A Pending JP2021514185A (ja) | 2018-02-14 | 2019-02-14 | Ｔ細胞系列の細胞を発生させるための方法 |
| JP2023191915A Active JP7866537B2 (ja) | 2018-02-14 | 2023-11-10 | Ｔ細胞系列の細胞を発生させるための方法 |
| JP2025216743A Pending JP2026031647A (ja) | 2018-02-14 | 2025-12-02 | Ｔ細胞系列の細胞を発生させるための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023191915A Active JP7866537B2 (ja) | 2018-02-14 | 2023-11-10 | Ｔ細胞系列の細胞を発生させるための方法 |
| JP2025216743A Pending JP2026031647A (ja) | 2018-02-14 | 2025-12-02 | Ｔ細胞系列の細胞を発生させるための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12467034B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3752602A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2021514185A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20200121817A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112041431A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2019220935B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3091158A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019157597A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3091158A1 (en) | 2018-02-14 | 2019-08-22 | Sunnybrook Research Institute | Method for generating cells of the t cell lineage |
| EP4237542A1 (en) * | 2020-10-28 | 2023-09-06 | Sangamo Therapeutics, Inc. | Generation of cd4+ effector and regulatory t cells from human pluripotent stem cells |
| AU2021386370A1 (en) | 2020-11-24 | 2023-06-22 | Lyell Immunopharma, Inc. | Methods for making, compositions comprising, and methods of using rejuvenated t cells |
| US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
| IL303269A (en) | 2020-12-03 | 2023-07-01 | Century Therapeutics Inc | Genetically engineered cells and uses thereof |
| EP4289940A4 (en) * | 2021-02-05 | 2025-02-26 | National University Corporation Kobe University | ?? T-CELLS FROM INDUCED PLURIPOTENT STEM CELLS AND PRODUCTION PROCESSES THEREFOR |
| AU2022253223A1 (en) | 2021-04-07 | 2023-09-28 | Century Therapeutics, Inc. | Combined artificial cell death/reporter system polypeptide for chimeric antigen receptor cell and uses thereof |
| CA3210702A1 (en) | 2021-04-07 | 2022-10-13 | Century Therapeutics, Inc. | Gene transfer vectors and methods of engineering cells |
| WO2022241558A1 (en) * | 2021-05-18 | 2022-11-24 | The University Of British Columbia | A method for producing blood progenitor and progenitor t cells, resulting cells and methods and uses thereof |
| WO2023129937A1 (en) | 2021-12-29 | 2023-07-06 | Century Therapeutics, Inc. | Genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereof |
| IL314801A (en) | 2022-02-22 | 2024-10-01 | Juno Therapeutics Inc | Proteinase 3 (PR3) Chimeric Autoantigen Receptor T Cells and Related Methods and Uses |
| JP2025515095A (ja) | 2022-05-04 | 2025-05-13 | センチュリー セラピューティクス，インコーポレイテッド | Ｈｌａ－ｅおよびｈｌａ－ｇ導入遺伝子を用いて操作された細胞 |
| US20250090582A1 (en) | 2022-06-08 | 2025-03-20 | Century Therapeutics, Inc. | Genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereof |
| EP4536814A1 (en) | 2022-06-08 | 2025-04-16 | Century Therapeutics, Inc. | Immunoeffector cells derived from induced pluripotent stem cells genetically engineered with membrane bound il12 and uses thereof |
| CN119630695A (zh) | 2022-06-08 | 2025-03-14 | 世纪治疗股份有限公司 | 表达cd16变体和nkg2d的遗传工程化细胞及其用途 |
| WO2024102838A1 (en) | 2022-11-09 | 2024-05-16 | Century Therapeutics, Inc. | Engineered interleukin-7 receptors and uses thereof |
| CN120435498A (zh) | 2022-11-10 | 2025-08-05 | 世纪治疗股份有限公司 | 具有抗-nectin4嵌合抗原受体的基因工程化细胞及其用途 |
| KR20250150555A (ko) * | 2023-01-27 | 2025-10-20 | 노치 테라퓨틱스 (캐나다) 인크. | 줄기세포/전구세포로부터 t 세포 계통 모집단을 생성하는 방법 |
| WO2025101938A2 (en) | 2023-11-10 | 2025-05-15 | Century Therapeutics, Inc. | Genetically engineered cells having multi-transmembrane domain chimeric antigen receptors utilizing g protein-coupled receptor scaffolds, and uses thereof |
| WO2025106626A1 (en) | 2023-11-15 | 2025-05-22 | Century Therapeutics, Inc. | Genetically engineered cells expressing c-x-c chemokine receptor type 4, and uses thereof |
| WO2025207795A1 (en) | 2024-03-26 | 2025-10-02 | Juno Therapeutics, Inc. | Genetically engineered cells having anti-cd33 / anti-cd123 chimeric antigen receptors, and uses thereof |
| WO2025207798A1 (en) | 2024-03-26 | 2025-10-02 | Century Therapeutics, Inc. | Genetically engineered cells having anti-cd123 chimeric antigen receptors, and uses thereof |
| US20250332260A1 (en) | 2024-04-10 | 2025-10-30 | Garuda Therapeutics, Inc. | Immune compatible cells for allogeneic cell therapies to cover global, ethnic, or disease-specific populations |
| US20260083778A1 (en) * | 2024-09-20 | 2026-03-26 | Boston Medical Center Corporation | Generation of cd4 t cells |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201043699A (en) | 2002-03-25 | 2010-12-16 | Takara Bio Inc | Process for producing cytotoxic lymphocyte |
| EP1492816A2 (en) * | 2002-04-05 | 2005-01-05 | Lorantis Limited | Modulators of the notch signalling pathway and uses thereof in medical treatment |
| US7575925B2 (en) * | 2002-12-10 | 2009-08-18 | Sunnybrook Health Sciences Centre | Cell preparations comprising cells of the T cell lineage and methods of making and using them |
| WO2004064863A1 (en) | 2003-01-23 | 2004-08-05 | Lorantis Limited | Treatment of autoimmune diseases using an activator for the notch signaling pathway |
| WO2007027226A2 (en) * | 2005-04-28 | 2007-03-08 | Board Of Regents, The University Of Texas System | Systems and methods for the production of differentiated cells |
| EP2321407A4 (en) | 2008-09-11 | 2012-07-18 | Univ Florida | SYSTEM AND METHOD FOR THE PRODUCTION OF T-CELLS |
| US8772028B2 (en) * | 2008-11-07 | 2014-07-08 | Sunnybrook Health Sciences Centre | CD34+CD7+CD5+CD1a-human progenitor T-cells produced in vitro and methods of using |
| US8871510B2 (en) | 2009-12-03 | 2014-10-28 | University Of Utah Research Foundation | Methods for generating T lymphocytes from hematopoietic stem cells |
| PL2539441T3 (pl) | 2010-02-22 | 2017-06-30 | Université Pierre Et Marie Curie (Paris 6) | Podłoże do hodowli komórkowej do wzrostu i różnicowania komórek linii hematopoetycznych |
| US9834754B2 (en) | 2011-11-21 | 2017-12-05 | University Health Network | Populations of hematopoietic progenitors and methods of enriching stem cells therefor |
| JP6449995B2 (ja) * | 2014-09-16 | 2019-01-09 | ヒタチ ゾウセン イノバ アクチェンゲゼルシャフト | 廃棄物焼却プラントの燃焼チャンバー内で発生するスラグを処理するための方法及び装置 |
| FR3026744B1 (fr) | 2014-10-06 | 2024-04-19 | Hopitaux Paris Assist Publique | Methode de generation de progeniteurs de cellules t |
| US10626372B1 (en) * | 2015-01-26 | 2020-04-21 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| WO2016187459A1 (en) | 2015-05-20 | 2016-11-24 | The Regents Of The University Of California | Method for generating human dendritic cells for immunotherapy |
| US12076342B2 (en) | 2016-04-08 | 2024-09-03 | The Governing Council Of The University Of Toronto | Method for generating progenitor t cells from stem and/or progenitor cells and use of same |
| US20190134169A1 (en) | 2016-04-26 | 2019-05-09 | Temple University-Of The Commonwealth System Of Higher Education | DLL4-expressing cells and vaccine using the same |
| ES2931530T3 (es) | 2017-02-13 | 2022-12-30 | Hopitaux Paris Assist Publique | Método para generar progenitores de células T |
| CA3091158A1 (en) | 2018-02-14 | 2019-08-22 | Sunnybrook Research Institute | Method for generating cells of the t cell lineage |
| EP4326856A4 (en) | 2021-04-23 | 2025-10-08 | Sunnybrook Res Inst | STEM CELLS COMPRISING AN UNREARRANGED T CELL RECEPTOR (TCR) GENE LOCUS AND METHODS OF USE THEREOF |
| WO2022241558A1 (en) | 2021-05-18 | 2022-11-24 | The University Of British Columbia | A method for producing blood progenitor and progenitor t cells, resulting cells and methods and uses thereof |
-
2019
- 2019-02-14 CA CA3091158A patent/CA3091158A1/en active Pending
- 2019-02-14 KR KR1020207024814A patent/KR20200121817A/ko not_active Ceased
- 2019-02-14 JP JP2020543276A patent/JP2021514185A/ja active Pending
- 2019-02-14 AU AU2019220935A patent/AU2019220935B2/en active Active
- 2019-02-14 WO PCT/CA2019/050181 patent/WO2019157597A1/en not_active Ceased
- 2019-02-14 US US16/969,854 patent/US12467034B2/en active Active
- 2019-02-14 CN CN201980025370.1A patent/CN112041431A/zh active Pending
- 2019-02-14 EP EP19754265.7A patent/EP3752602A4/en active Pending
-
2023
- 2023-11-10 JP JP2023191915A patent/JP7866537B2/ja active Active
-
2025
- 2025-06-17 AU AU2025204516A patent/AU2025204516A1/en active Pending
- 2025-10-20 US US19/363,170 patent/US20260043003A1/en active Pending
- 2025-12-02 JP JP2025216743A patent/JP2026031647A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Aqmasheh et al. | Effects of mesenchymal stem cell derivatives on hematopoiesis and hematopoietic stem cells | |
| Salem et al. | Mesenchymal stromal cells: current understanding and clinical status | |
| Seshi et al. | Human bone marrow stromal cell: coexpression of markers specific for multiple mesenchymal cell lineages | |
| Bonnet | Biology of human bone marrow stem cells | |
| Pappa et al. | Novel sources of fetal stem cells: where do they fit on the developmental continuum? | |
| Timmermans et al. | Generation of T cells from human embryonic stem cell-derived hematopoietic zones | |
| Elahi et al. | Human mesenchymal stromal cells from different sources diverge in their expression of cell surface proteins and display distinct differentiation patterns | |
| Ratajczak et al. | Adult murine bone marrow-derived very small embryonic-like stem cells differentiate into the hematopoietic lineage after coculture over OP9 stromal cells | |
| K. Batsali et al. | Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications | |
| Cheng et al. | Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture | |
| Bauer et al. | New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133) | |
| JP2019528771A5 (cg-RX-API-DMAC7.html) | ||
| de Pooter et al. | In vitro generation of T lymphocytes from embryonic stem cell–derived prehematopoietic progenitors | |
| Phuc et al. | Isolation of three important types of stem cells from the same samples of banked umbilical cord blood | |
| McGuckin et al. | Potential for access to embryonic‐like cells from human umbilical cord blood | |
| JP2025024025A (ja) | ナチュラルキラー細胞に分化させるための培地および方法 | |
| JP2022534397A5 (cg-RX-API-DMAC7.html) | ||
| Girdlestone et al. | Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions | |
| Signore et al. | Identity and ranking of colonic mesenchymal stromal cells | |
| Lanzoni et al. | Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease | |
| TW200936148A (en) | Methods for co-culturing cord blood derived cells with menstrual stem cells | |
| Pievani et al. | Harnessing mesenchymal stromal cells for the engineering of human hematopoietic niches | |
| Huyghe et al. | Comparative analysis of iPSC-derived NK cells from two differentiation strategies reveals distinct signatures and cytotoxic activities | |
| EP4352208A1 (en) | A method for producing blood progenitor and progenitor t cells, resulting cells and methods and uses thereof | |
| Orticelli et al. | Human amniotic mesenchymal stromal cells support the ex vivo expansion of cord blood hematopoietic stem cells |